These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15122397)

  • 1. [Importing medicines with quality assurance].
    Agência Nacional de Vigilância Sanitária - Anvisa
    Rev Saude Publica; 2004 Apr; 38(2):337-8. PubMed ID: 15122397
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Canada's Progressive Licensing Framework.
    Yeates N; Lee DK; Maher M
    CMAJ; 2007 Jun; 176(13):1845-7. PubMed ID: 17576983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monitoring cosmetic product safety].
    Vigan M
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S55-8. PubMed ID: 17563716
    [No Abstract]   [Full Text] [Related]  

  • 5. Bad medicine. Monitoring programs target substandard drugs.
    Grens K
    Mod Healthc; 2013 May; 43(20):30-1. PubMed ID: 23947275
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimation of potency of Hepatitis B immunoglobulin marketed in India to evaluate the manufacturer's production consistency: Role of National Control Laboratory.
    Meena J; Sood S; Rani N; Bisht R; Kiran M; Chhabra R; Singh S; Chand S
    Biologicals; 2019 May; 59():72-73. PubMed ID: 30917901
    [No Abstract]   [Full Text] [Related]  

  • 7. Aerosolised pentamidine and public health.
    McDiarmid MA; Jacobson-Kram D
    Lancet; 1989 Oct; 2(8667):863-4. PubMed ID: 2571783
    [No Abstract]   [Full Text] [Related]  

  • 8. Barriers and Opportunities for Use of Patient Registries in Medicines Regulation.
    Olmo CA; McGettigan P; Kurz X
    Clin Pharmacol Ther; 2019 Jul; 106(1):39-42. PubMed ID: 30970160
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for company-sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993).
    Br J Clin Pharmacol; 1994 Aug; 38(2):95-7. PubMed ID: 7981019
    [No Abstract]   [Full Text] [Related]  

  • 10. Setting new standards for customer advocacy.
    McDonald L
    J Bus Strategy; 1993; 14(1):11-5. PubMed ID: 10123419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of medicines in Europe.
    Griffin JP
    J R Coll Physicians Lond; 1993 Oct; 27(4):386. PubMed ID: 8289158
    [No Abstract]   [Full Text] [Related]  

  • 12. Making 'safety first' a reality for biotechnology products.
    Kapuscinski AR; Goodman RM; Hann SD; Jacobs LR; Pullins EE; Johnson CS; Kinsey JD; Krall RL; La Viña AG; Mellon MG; Ruttan VW
    Nat Biotechnol; 2003 Jun; 21(6):599-601. PubMed ID: 12776139
    [No Abstract]   [Full Text] [Related]  

  • 13. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Canada targets postmarket surveillance of drugs.
    Sibbald B
    CMAJ; 2002 Jun; 166(12):1580. PubMed ID: 12074132
    [No Abstract]   [Full Text] [Related]  

  • 15. Identity tags.
    Pauli U
    Nat Biotechnol; 2003 Jun; 21(6):598. PubMed ID: 12776138
    [No Abstract]   [Full Text] [Related]  

  • 16. Identity tags revisited.
    Marillonnet S; Klimyuk V; Gleba Y
    Nat Biotechnol; 2003 Sep; 21(9):974-5; author reply 975. PubMed ID: 12949551
    [No Abstract]   [Full Text] [Related]  

  • 17. EU and US clinical investigation adverse event reporting.
    Crowley G
    Med Device Technol; 2004 Jun; 15(5):30-2. PubMed ID: 15285486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory and microbiological safety issues surrounding cell and tissue-engineering products.
    Galbraith DN
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):35-9. PubMed ID: 15270705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing modifications in the safety labeling of the new antiepileptics.
    Buck ML; Gurka MJ; Goodkin HP
    Neurology; 2007 May; 68(18):1536-7. PubMed ID: 17470758
    [No Abstract]   [Full Text] [Related]  

  • 20. Encoding technical information in GM organisms.
    Marillonnet S; Klimyuk V; Gleba Y
    Nat Biotechnol; 2003 Mar; 21(3):224-6. PubMed ID: 12610560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.